ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms

Affiliations

• ¹ Benign Hematology & Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
• ² Department of Medicine, The Mount Sinai Hospital, New York, NY, USA.
• ³ Department of Biostatistics & Bioinformatic, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
• ⁴ Virginia Polytechnic Institute and State University, Center for Biostatistics and Health Data Science, Blacksburg, VA, USA.
• ⁵ Department of Medicine, Rochester Regional Health, Rochester General Hospital, Rochester, NY, USA.
• ⁶ Tisch Cancer Institute, Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ⁷ Benign Hematology & Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. aelshoury@wnybloodcare.org.
• ⁸ Western New York BloodCare, Buffalo, NY, USA. aelshoury@wnybloodcare.org.